Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$612K Buy
5,090
+850
+20% +$98.1K 0.2% 95
2025
Q4
$446K Buy
4,240
+228
+6% +$21.4K 0.12% 114
2025
Q3
$337K Sell
4,012
-26
-0.6% -$2.14K 0.12% 128
2025
Q2
$320K Sell
4,038
-184
-4% -$14.6K 0.12% 129
2025
Q1
$379K Buy
+4,222
New +$394K 0.17% 103
2024
Q4
Sell
-4,681
Closed -$532K 118
2024
Q3
$532K Buy
+4,681
New +$556K 0.29% 67

Other funds holding MRK

Elyxium Wealth's MRK Position: Q1 2026 in Review

Elyxium Wealth increased its Merck (MRK) stake by 20% in Q1 2026, buying an estimated $98.1K and bringing the position to 5,090 shares worth $612K. The position accounts for 0.2% of the portfolio, ranked #95.

Elyxium Wealth first reported a position in MRK in Q3 2024 and has held it in 6 quarters since. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Elyxium Wealth held 5,090 shares of Merck worth $612K as of Q1 2026.
  • Elyxium Wealth bought 850 Merck shares in Q1 2026, an estimated $98.1K.
  • Merck made up 0.2% of Elyxium Wealth's portfolio in Q1 2026, its #95 holding.
  • Elyxium Wealth first reported a position in Merck in Q3 2024 and has held it in 6 quarters since.
  • 3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.